Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.06−2.59 (-2.92%)
Close on Nov 17, 2026Market cap $14.65BP/E 96.7Yield –
Solventum revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Solventum's revenue for the twelve months ending Sep 30, 2026 was $8.16B, down 2.8% year over year. For fiscal 2025 it was $8.33B, up 0.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.33B | +0.9% |
| FY2024 | Dec 31, 2024 | $8.25B | +0.7% |
| FY2023 | Dec 31, 2023 | $8.20B | +0.8% |
| FY2022 | Dec 31, 2022 | $8.13B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.95B | -7.0% |
| Q2 FY2026 | Jun 30, 2026 | $2.21B | +2.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.01B | -3.0% |
| Q4 FY2025 | Dec 31, 2025 | $2.00B | -3.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.10B | +0.7% |
| Q2 FY2025 | Jun 30, 2025 | $2.16B | +3.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.07B | +2.7% |
| Q4 FY2024 | Dec 31, 2024 | $2.08B | +1.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.08B | +0.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.08B | +0.2% |
| Q1 FY2024 | Mar 31, 2024 | $2.02B | +0.2% |
| Q4 FY2023 | Dec 31, 2023 | $2.04B | – |
| Q3 FY2023 | Sep 30, 2023 | $2.07B | – |
| Q2 FY2023 | Jun 30, 2023 | $2.08B | – |
| Q1 FY2023 | Mar 31, 2023 | $2.01B | – |
See a number that looks wrong?